Biopsy Guidance System Market Size Worth $1,383.5 Million By 2028: Grand View Research, Inc. – Press Release

SAN FRANCISCO, July 14, 2021 /PRNewswire/ — The global biopsy guidance system market size is expected to reach USD 1,383.5 million by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 5.2% from 2021 to 2028. The increasing prevalence of cancer, rise in the geriatric population, growing demand for non-invasive procedures, technological innovations, a rising number of government initiatives, and impact of COVID-19 are the key driving factors for the market.

Key Insights & Findings:

• In terms of product, the stereotactic guided biopsy segment held the largest revenue share in 2020 and the ultrasound-guided biopsy segment is estimated to be the fastest-growing segment over the forecast period
• In terms of application, the brain biopsy segment held the largest revenue share in 2020 and the breast biopsy segment is estimated to be the fastest-growing segment during the forecast period. The rising prevalence of brain cancer is the major factor driving the demand for brain biopsies
• In terms of end-use, the hospital segment held the largest revenue share in 2020. The hospital segment’s dominance is majorly attributed to the higher biopsy guiding system utilization in hospitals
• North America dominated the market in 2020 owing to numerous factors such as enhanced infrastructure, rising patient awareness, and the presence of key players in the region

Read 90 page market research report, “Biopsy Guidance System Market Size, Share & Trends Analysis Report By Product (Stereotactic Guided Biopsy, MRI Guided Biopsy), By Application, By End-use (Hospitals, Specialty Clinics), By Region, And Segment Forecasts, 2021 – 2028“, by Grand View Research.

A biopsy is one of the most prominent procedures for diagnosing cancer amongst other chronic diseases, and it is commonly employed in the diagnosis of breast, brain, skin, and prostate cancer. The increasing prevalence of cancer is a major factor responsible for market growth. For instance, according to Cancer.org, in 2021, around 1.9 million new cancer cases are expected to be diagnosed in the US. Since the biopsy guidance system is one of the major requirements for the initial diagnosis of cancer, thus, rising number of cancer cases is anticipated to propel market growth over the forecast period

Furthermore, there is a rising preference for minimally invasive biopsy treatments in the market. During the forecast period, several types of technologies and products including robot-assisted biopsy guidance systems, needle-based biopsy guns, and vacuum-assisted core biopsy systems, are expected to expand rapidly. For instance, in March 2021, IZI Medical Products, LLC launched Quick-Core Auto Biopsy System for soft tissue biopsy. It is a lightweight, completely automatic biopsy device and provides reliability, quality, and accuracy. Additionally, rising awareness of breast cancer treatment and diagnosis will further boost market growth over the forecast period.

Grand View Research has segmented the global biopsy guidance system market on the basis of product, application, end-use, and region:

• Biopsy Guidance System Product Outlook (Revenue, USD Million, 2016 – 2028)
• Stereotactic Guided Biopsy
• Ultrasound Guided Biopsy
• MRI Guided Biopsy
• Biopsy Guidance System Application Outlook (Revenue, USD Million, 2016 – 2028)
• Brain Biopsy
• Breast Biopsy
• Other Applications
• Biopsy Guidance System End-use Outlook (Revenue, USD Million, 2016 – 2028)
• Hospitals
• Specialty Clinics
• Diagnostic Centers
• Research and Academic Institutes
• Biopsy Guidance System Regional Outlook (Revenue, USD Million, 2016 – 2028)
• North America
• Europe
• Asia Pacific
• Latin America
• MEA
• South Africa
• Saudi Arabia

List of Key Players of Biopsy Guidance System Market

• Becton, Dickinson, and Company
• Hologic, Inc.
• Devicor Medical Products, Inc.
• B. Braun Melsungen AG
• ARGON MEDICAL
• Boston Scientific Corporation
• INRAD Inc.
• Cook Medical
• PLANMED OY

Check out more studies related to biopsy devices, by Grand View Research:

• Breast Biopsy Device Market– The Breast Biopsy Device Market size was estimated to be USD 372.9 million in 2015.
• Biopsy Devices Market– The global biopsy devices market size was estimated at USD 1.0 billion in 2016.
• Smart Biopsy Devices Market– The global smart biopsy devices market size was valued at USD 2.40 billion in 2018 and is anticipated to expand at a CAGR of 5.6% over the forecast period.

Browse through Grand View Research’s coverage of the Global Medical Devices Industry.

Gain access to Grand View Compass, our BI enabled intuitive market research database of 10,000+ reports

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com 
Web: https://www.grandviewresearch.com 
Follow Us: LinkedIn | Twitter

View original content:https://www.prnewswire.com/news-releases/biopsy-guidance-system-market-size-worth-1-383-5-million-by-2028-grand-view-research-inc-301333411.html

SOURCE Grand View Research, Inc.